Prostate Cancer Clinical Trials

Showing 2081-2100 of 2,150 trials

Prophylactic Urethral Stenting With Memokath After Prostate Implantation for Prostate Adenocarcinoma

NCT00252941

The purpose of this study is to determine the feasibility, safety, and efficacy of the Memokath® 028SW stent to prevent urinary obstructive symptoms (difficulty urinating) when used after prostate seed implantation for the treatment of localized prostate cancer.

Prostate CancerPost-Brachytherapy Bladder Outlet Obstruction

The Cleveland Clinic20 participantsStarted Nov 2005

Cleveland, Ohio, United States

COMPLETED

Observational Retrospective Trial on Sequential Hormonal Therapy in Patients With Prostate Cancer

NCT00668083

Observational Retrospective trial on sequential hormonal therapy in patients with Prostate Cancer

Prostate Cancer

AstraZeneca214 participantsStarted Sep 2007

Acquaviva delle Fonti, Italy • Ancona, Italy • Florence, Italy +9 more locations

COMPLETEDPhase 3

(Bicalutamide) Casodex vs Placebo in Non-metastatic Early Prostate Cancer

NCT00673205

The purpose of this trial is to study the effect of adjuvant or immediate hormonal therapy, versus placebo, in subjects who have either undergone a primary therapy (principally radical prostatectomy or radiotherapy) or who were otherwise to be managed by watchful waiting.

Non-Metastatic Prostate Cancer

AstraZeneca3,588 participantsStarted Sep 1995

Wooloongabba, Queensland, Australia • East Melbourne, Victoria, Australia • Graz, Austria +125 more locations

Prophylactic Urethral Stenting With Memokath After Prostate Implantation for Prostate Adenocarcinoma

Observational Retrospective Trial on Sequential Hormonal Therapy in Patients With Prostate Cancer

(Bicalutamide) Casodex vs Placebo in Non-metastatic Early Prostate Cancer

Related Searches

A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer

Quality of Life Analysis of Treatment in Patients With Prostate Cancer on Adjuvant Zoladex Therapy

Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer

Study of Patupilone in Prostate Cancer Patients Who Progress After Hormone Therapy and Docetaxel Chemotherapy

Evaluation of the Efficacy and Safety of Common Sage in Controlling Hot Flashes in Prostate Cancer Patients Treated by Androgen Deprivation

Immunotherapy With APC8015 (Sipuleucel-T, Provenge) for Asymptomatic, Metastatic, Hormone-Refractory Prostate Cancer

Biomarker Study for Sunitinib and Docetaxel in Prostate Cancer

Shorter Radiation Schedule for the Treatment of Prostate Cancer

Does Postoperative Gabapentin Reduce Pain, Opioid Consumption and Anxiety and Have a Positive Effect on Health Related Quality of Life After Radical Prostatectomy?

Weekly Paclitaxel, Low-Dose Estramustine, and Carboplatin in the Treatment of Hormone Refractory Prostate Carcinoma

Phase II/III Study of WST09 in Prostate Cancer After Radiation Therapy

Safety of LBH589 Alone and in Combination With Intravenous Docetaxel and Prednisone

The Effectiveness of 18F-fluorocholine Positron Emission Tomography (PET) in Detecting, Staging and Following-up Prostate Cancer

Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer

Computed Tomography (CT) Scans Using CT-On-Rails™ to Pinpoint the Location of the Tumor in Treating Patients With Prostate Cancer

Casodex/Zoladex Hormonal therApy Study for assessMent of Correlation Between PSA & BAI in prOstate Cancer patieNts

Treatment Decision Making in Early-Stage Prostate Cancer